The company has initiated and in process to start of production facilities as per PIC/S guidelines for oral and injectables dosage along with Lyophilization in the therapeutic segment of Oncology.

The company has developed certain new formulations under the segment of Antiretrovirals and Immunosuppressants.

The plant of the company and its associates are undergoing inspection for approval of PIC/S certification.


Today LOK-BETA is a key player in the Indian market, with a wide range of products in various segments such as Antiinflammatory, Neutraceuticals, Antimalarial and Antihypertensive.

LOK-BETA enjoys a strong rapport with the medical profession including specialist, who have accepted LOK-BETA’s product for their High quality, efficacy and affordability.

LOK-BETA has built up a strong equity with a vast and efficient DEALER NETWORK.

LOK-BETA has a strong presence with its own team in the states of UP Jharkhand and Bihar.

LOK-BETA has launched new products in the market such as C2, Presscoff and planning to launch products of niche segments.
© 2009 Lok Beta Pvt. Ltd. All rights reserved.
Sitemap   |   Privacy Policy   |   Credits